-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
November 01, 2014 - Potential harms also include side effects or complications of treatments. … Long-term harms of HIV antiretroviral therapy.
Sexually transmitted
infections
2. … Studies are needed that include psychotherapy and combined treatments
and focus on MDD alone, as well … inhibitors and complementary or alternative treatments). … Studies on the effectiveness of antiretroviral therapy, adherence to treatment, and
behavioral counseling
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/kXAtzuxCxKJcHK9Fg63GA3
April 01, 2023 - The USPSTF reviewed
evidence on interventions (behavioral counseling and pharmaco-
therapy) for weight … behavioral therapy, and consid-
eration of pharmacotherapy according to US Food and Drug Admin-
istration … Screening for
prediabetes and type 2 diabetes in children and
adolescents: US Preventive Services Task … Hilliard ME, Lawrence JM, Modi AC, et al;
SEARCH for Diabetes in Youth Study Group. … Diabetes Care. 2013;36(7):1891-1897.
doi:10.2337/dc12-1708
14. American Academy of Pediatrics.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
January 01, 1996 - factors for coronary heart disease are smoking, high blood pressure, elevated serum cholesterol, obesity, diabetes … discuss aspirin prophylaxis with men who have risk factors for MI (e.g., high blood cholesterol, smoking, diabetes … risks of aspirin therapy before beginning treatment. … Foster JW, Hart RG Antithrombotic therapy for cerebrovascular disease: prevention and treatment of stroke … Fuster V, Dyken ML, Vokonas PS, et al Aspirin as a therapeutic agent in cardiovascular disease.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan142/obstructive-sleep-apnea-in-adults-screening
October 30, 2014 - Is there an association between OSA and incident diabetes? … assessments may occur in sleep laboratories or other settings)
KQs 4, 5, 8: For nonsurgical treatments … of allergic rhinitis or similar treatments that might secondarily improve OSA by treating another condition … Studies focusing on potential worsening of OSA that might be caused by treatments for other … or inactive mandibular advancement devices; surgery vs. sham, conservative treatment, or no treatment
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan142/obstructive-sleep-apnea-in-adults-screening-january-2017
October 30, 2014 - Is there an association between OSA and incident diabetes? … assessments may occur in sleep laboratories or other settings)
KQs 4, 5, 8: For nonsurgical treatments … of allergic rhinitis or similar treatments that might secondarily improve OSA by treating another condition … Studies focusing on potential worsening of OSA that might be caused by treatments for other … or inactive mandibular advancement devices; surgery vs. sham, conservative treatment, or no treatment
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-97QgoUF_rpQSy-9yM9KCx
November 24, 2020 - Treatment guidelines for hypertension and
dyslipidemia have changed, generally recommending treatment … Clinical and cost outcomes of medical
nutrition therapy for hypercholesterolemia:
a controlled trial. … Motivational interviewing and problem solving
treatment to reduce type 2 diabetes and
cardiovascular … The Hypertension
Optimal Treatment Study (the HOT Study). … One-year follow-up
of a therapeutic lifestyle intervention targeting
cardiovascular disease risk.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/4NUuvS6nmzTdBgjBg3ELkE
January 01, 2020 - start medication for dyslip-
idemia or increased glucose levels or to start nicotine re-
placement therapy … Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–
1994 and 2005–2006. … Sodium reduction and weight loss in the treatment of hyperten-
sion in older persons: a randomized controlled … Motivational interviewing and problem solving treatment to reduce
type 2 diabetes and cardiovascular … Effective-
ness of primary care-relevant treatments for obesity in adults: a systematic
evidence review
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan36/carotid-artery-stenosis-screening-december-2007
January 23, 2014 - Treatment/ management interventions
CEA, CAAS, medical therapy (e.g., aspirin, statins, antiplatelet … medical therapy (that includes treatment of traditional risk factors). … Risk stratification tools may include clinical factors (e.g., age, diabetes) and anatomic or imaging … treatment. … The USPSTF received several comments requesting that it consider the evidence on medical therapies for
-
www.uspreventiveservicestaskforce.org/uspstf/document/ResearchPlanFinal/carotid-artery-stenosis-screening-december-2007
January 23, 2014 - Treatment/ management interventions
CEA, CAAS, medical therapy (e.g., aspirin, statins, antiplatelet … medical therapy (that includes treatment of traditional risk factors). … Risk stratification tools may include clinical factors (e.g., age, diabetes) and anatomic or imaging … treatment. … The USPSTF received several comments requesting that it consider the evidence on medical therapies for
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-XKf9dRtb-S6oSsBzwsCdw
December 08, 2003 - Department of
Health and Human Services of a particular drug, device, test, treatment, or other clinical … Some of these treatments are directed at traditional risk factors (e.g.,
statins for hyperlipidemia … Little information, however, is
available to determine if such treatment is effective in asymptomatic … with medications, such as
beta-blockers, or revascularization can improve outcomes over no treatment … Presentation, diagnosis, treatment, and 28-day case
fatality of 3991 events in men and 1551 events in
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
January 01, 2002 - rate of nonfatal myocardial infarction against potential adverse effects. 13 In 2000, the American Diabetes … lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment … Aspirin Therapy in Diabetes. American Diabetes Association. … Diabetes Care 2001;24(suppl 10):S62-S63. … Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening
May 02, 2023 - 25 Some evidence from observational studies has explored the association between poorly controlled diabetes … However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes … tuberculosis exposure, HIV infection, risk factors increasing risk of progression to active disease (such as diabetes … Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KdQef_VDT2kmHDX4ddNWmR
August 01, 2022 - .25 Some evidence from observational studies
has explored the association between poorly controlled diabetes … However, there is insuffi-
cient evidence on screening for and treatment of LTBI in persons
with diabetes … tuberculosis exposure, HIV infec-
tion, risk factors increasing risk of progression to active disease (such
as diabetes … Efficacy of
various durations of isoniazid preventive therapy
for tuberculosis: five years of follow-up … Adverse
events with 4 months of rifampin therapy or 9
months of isoniazid therapy for latent tuberculosis
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/unhealthy-alcohol-use-adolescents-adults-behavioral-counseling-interventions
February 01, 2024 - how structural and social determinants of health affect risk for unhealthy alcohol use and access to treatment … not generalizable to primary care (e.g., psychiatric inpatients, persons who are court-mandated to treatment … Counseling interventions can vary in their approach (e.g., 12-step program, cognitive behavioral therapy … , or motivational enhancement therapy), specific strategies, delivery method (e.g., face-to-face, electronic … settings (e.g., diabetes management and dialysis clinics); research clinics; and office, home, or other
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthful-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-behavioral-counseling
June 04, 2012 - Recommendation
Grade
General adult population without a known diagnosis of hypertension, diabetes … available to quantify a person's 10-year risk for cardiac events, such as the Framingham-based Adult Treatment … small net benefit in adult patients without cardiovascular disease, hypertension, hyperlipidemia, or diabetes … It does not apply to adults who have known CVD, hypertension, hyperlipidemia, or diabetes. … The Framingham-based Adult Treatment Panel III calculator (available at http://hp2010.nhlbihin.net/atpiii
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthful-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-behavioral-counseling-2012
June 04, 2012 - Recommendation
Grade
General adult population without a known diagnosis of hypertension, diabetes … available to quantify a person's 10-year risk for cardiac events, such as the Framingham-based Adult Treatment … small net benefit in adult patients without cardiovascular disease, hypertension, hyperlipidemia, or diabetes … It does not apply to adults who have known CVD, hypertension, hyperlipidemia, or diabetes. … The Framingham-based Adult Treatment Panel III calculator (available at http://hp2010.nhlbihin.net/atpiii
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/M2VPMGyADx9SCTCPaayYN4
July 01, 2014 - main risk
factors are older age, being male, high blood pressure, smoking, high blood cholesterol, diabetes … Screening and Treatment for Carotid Artery Stenosis
Carotid artery stenosis screening is often done … The main treatments for patients with carotid artery stenosis are lifestyle changes, medicines, and surgery … Potential Benefits and Harms of Carotid Artery Stenosis Screening and Treatment
The Task Force reviewed … The Task Force recommendations do not cover diagnosis (tests to find out why you are sick)
or treatment
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/chronic-obstructive-pulmonary-disease-screening
May 10, 2022 - to stop smoking. 12
Pharmacologic therapies (eg, bronchodilators and anti-inflammatory therapies) … (LABAs), long-acting muscarinic antagonists (LAMAs), inhaled corticosteroids (ICS), or combination therapy … cardiovascular risk association with LABAs or LAMAs was absent, or even reduced, with prevalent use of inhaled therapy … A second study found that ICS may increase the risk of developing diabetes (n = 9923 for diabetes onset … The USPSTF describes the benefits and harms of pharmacologic and nonpharmacologic COPD treatments in
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/mggnaKHr496c8QCgHe9-tm
May 01, 2021 - to stop smoking.12
Pharmacologic therapies (eg, bronchodilators and anti-
inflammatory therapies) and … LABAs), long-acting muscarinic an-
tagonists (LAMAs), inhaled corticosteroids (ICS), or combination
therapy … cardiovascular risk association with LABAs or
LAMAs was absent, or even reduced, with prevalent use of inhaled
therapy … A second study found that ICS may increase the risk of de-
veloping diabetes (n = 9923 for diabetes onset … The USPSTF describes the benefits and
harms of pharmacologic and nonpharmacologic COPD treatments
in
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary17/coronary-heart-disease-screening-with-electrocardiography-2012
September 15, 2011 - Data Synthesis: No study evaluated clinical outcomes or use of risk-reducing therapies after screening … including resting or exercise electrocardiography (ECG), might help better guide use of risk-reduction therapies … Other USPSTF reviews 10 , 11 have evaluated adverse outcomes associated with lipid-lowering therapy … Risk refinement, reclassification, and treatment thresholds in primary prevention of cardiovascular disease … Risk stratification and therapeutic decision making in acute coronary syndromes.